logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Ocular Hypertension

    Medications for Ocular Hypertension

    FiltersReset Filters
    42 results

    • azopt

      (brinzolamide)
      Sandoz Inc
      Usage: AZOPT is indicated for treating elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma as a carbonic anhydrase inhibitor.

    • betoptic s

      (betaxolol hydrochloride)
      Novartis Pharmaceuticals Corporation
      Usage: BETOPTIC S (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Alembic Pharmaceuticals Inc.
      Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Fosun Pharma USA Inc.
      Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Somerset Therapeutics, LLC
      Usage: Bimatoprost ophthalmic solution 0.03% is indicated for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • brimonidine

      (brimonidine tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution is an alpha adrenergic receptor agonist used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • brimonidine tartrate

      (Brimonidine Tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution, 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Its effectiveness may diminish over time, necessitating close monitoring of IOP in patients.

    • brimonidine tartrate

      (Brimonidine Tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution, 0.15%, is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • brimonidine tartrate

      (Brimonidine Tartrate)
      Florida Pharmaceutical Products, LLC
      Usage: Brimonidine tartrate ophthalmic solution, 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Its efficacy may diminish over time, necessitating close monitoring for each patient.

    • brimonidine tartrate

      (Brimonidine Tartrate)
      Alembic Pharmaceuticals Inc.
      Usage: Brimonidine tartrate ophthalmic solution, 0.1% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.